These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 15101048

  • 1. Correlation between histone acetylation and expression of the MYO18B gene in human lung cancer cells.
    Tani M, Ito J, Nishioka M, Kohno T, Tachibana K, Shiraishi M, Takenoshita S, Yokota J.
    Genes Chromosomes Cancer; 2004 Jun; 40(2):146-51. PubMed ID: 15101048
    [Abstract] [Full Text] [Related]

  • 2. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, Plass C.
    J Natl Cancer Inst; 2006 Mar 15; 98(6):396-406. PubMed ID: 16537832
    [Abstract] [Full Text] [Related]

  • 3. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
    Osada H, Tatematsu Y, Sugito N, Horio Y, Takahashi T.
    Mol Carcinog; 2005 Dec 15; 44(4):233-41. PubMed ID: 16163707
    [Abstract] [Full Text] [Related]

  • 4. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y, Fatima N, Dufau ML.
    Mol Cell Biol; 2005 Sep 15; 25(18):7929-39. PubMed ID: 16135786
    [Abstract] [Full Text] [Related]

  • 5. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model.
    El-Khoury V, Breuzard G, Fourré N, Dufer J.
    Br J Cancer; 2007 Aug 20; 97(4):562-73. PubMed ID: 17667922
    [Abstract] [Full Text] [Related]

  • 6. Histone H3 acetylation is associated with reduced p21(WAF1/CIP1) expression by gastric carcinoma.
    Mitani Y, Oue N, Hamai Y, Aung PP, Matsumura S, Nakayama H, Kamata N, Yasui W.
    J Pathol; 2005 Jan 20; 205(1):65-73. PubMed ID: 15586362
    [Abstract] [Full Text] [Related]

  • 7. Loss of retinoic acid receptor beta gene expression is linked to aberrant histone H3 acetylation in lung cancer cell lines.
    Suh YA, Lee HY, Virmani A, Wong J, Mann KK, Miller WH, Gazdar A, Kurie JM.
    Cancer Res; 2002 Jul 15; 62(14):3945-9. PubMed ID: 12124324
    [Abstract] [Full Text] [Related]

  • 8. Genetic and epigenetic alterations of the candidate tumor-suppressor gene MYO18B, on chromosome arm 22q, in colorectal cancer.
    Nakano T, Tani M, Nishioka M, Kohno T, Otsuka A, Ohwada S, Yokota J.
    Genes Chromosomes Cancer; 2005 Jun 15; 43(2):162-71. PubMed ID: 15751041
    [Abstract] [Full Text] [Related]

  • 9. Differential modulation of nuclear texture, histone acetylation, and MDR1 gene expression in human drug-sensitive and -resistant OV1 cell lines.
    Yatouji S, El-Khoury V, Trentesaux C, Trussardi-Regnier A, Benabid R, Bontems F, Dufer J.
    Int J Oncol; 2007 Apr 15; 30(4):1003-9. PubMed ID: 17332941
    [Abstract] [Full Text] [Related]

  • 10. Histone deacetylation directs DNA methylation in survivin gene silencing.
    Ma AN, Lu J, Zhou XJ, Wang YX.
    Biochem Biophys Res Commun; 2011 Jan 07; 404(1):268-72. PubMed ID: 21130077
    [Abstract] [Full Text] [Related]

  • 11. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY, Lai KP, Lui WC, Wan HT, Wong CK.
    Exp Cell Res; 2008 Oct 01; 314(16):2975-84. PubMed ID: 18652825
    [Abstract] [Full Text] [Related]

  • 12. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, Helin K, Liao WS, Yu Y.
    Oncogene; 2006 Jan 12; 25(2):230-9. PubMed ID: 16158053
    [Abstract] [Full Text] [Related]

  • 13. Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines.
    Osada H, Tatematsu Y, Masuda A, Saito T, Sugiyama M, Yanagisawa K, Takahashi T.
    Cancer Res; 2001 Nov 15; 61(22):8331-9. PubMed ID: 11719467
    [Abstract] [Full Text] [Related]

  • 14. Cyclin D1 gene activation in human myeloma cells is independent of DNA hypomethylation or histone hyperacetylation.
    Krieger S, Grunau C, Sabbah M, Sola B.
    Exp Hematol; 2005 Jun 15; 33(6):652-9. PubMed ID: 15911089
    [Abstract] [Full Text] [Related]

  • 15. Effects of the histone deacetylase inhibitor trichostatin A on nuclear texture and c-jun gene expression in drug-sensitive and drug-resistant human H69 lung carcinoma cells.
    El-Khoury V, Gomez D, Liautaud-Roger F, Trussardi-Régnier A, Dufer J.
    Cytometry A; 2004 Dec 15; 62(2):109-17. PubMed ID: 15517561
    [Abstract] [Full Text] [Related]

  • 16. Plakoglobin is differentially expressed in alveolar and embryonal rhabdomyosarcoma and is regulated by DNA methylation and histone acetylation.
    Gastaldi T, Bonvini P, Sartori F, Marrone A, Iolascon A, Rosolen A.
    Carcinogenesis; 2006 Sep 15; 27(9):1758-67. PubMed ID: 16537559
    [Abstract] [Full Text] [Related]

  • 17. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer.
    Wang LG, Beklemisheva A, Liu XM, Ferrari AC, Feng J, Chiao JW.
    Mol Carcinog; 2007 Jan 15; 46(1):24-31. PubMed ID: 16921492
    [Abstract] [Full Text] [Related]

  • 18. Epigenetic patterns of the retinoic acid receptor beta2 promoter in retinoic acid-resistant thyroid cancer cells.
    Cras A, Darsin-Bettinger D, Balitrand N, Cassinat B, Soulié A, Toubert ME, Delva L, Chomienne C.
    Oncogene; 2007 Jun 07; 26(27):4018-24. PubMed ID: 17213810
    [Abstract] [Full Text] [Related]

  • 19. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
    Abbosh PH, Montgomery JS, Starkey JA, Novotny M, Zuhowski EG, Egorin MJ, Moseman AP, Golas A, Brannon KM, Balch C, Huang TH, Nephew KP.
    Cancer Res; 2006 Jun 01; 66(11):5582-91. PubMed ID: 16740693
    [Abstract] [Full Text] [Related]

  • 20. Transcriptional regulation of IRS5/DOK4 expression in non-small-cell lung cancer cells.
    Gray SG, Al-Sarraf N, Baird AM, Gately K, McGovern E, O'Byrne KJ.
    Clin Lung Cancer; 2008 Nov 01; 9(6):367-74. PubMed ID: 19073520
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.